Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Human Papillomavirus-Related Cervical Carcinoma 1

Interventions

Specimen Handling 322 Magnetic Resonance Spectroscopy 219 Biopsy 186 Nivolumab 50 X-Rays 45 Radiation 42 Immunoglobulin G 42 Disulfides 42 Paclitaxel 40 Cyclophosphamide 40 pembrolizumab 39 Taxes 39 Cisplatin 39 Platinum 37 1,2-diaminocyclohexaneplatinum II citrate 37 Carboplatin 36 Radiotherapy 33 atezolizumab 30 Doxorubicin 30 olaparib 25 Gemcitabine 25 venetoclax 24 Ipilimumab 24 CTLA-4 Antigen 24 Bevacizumab 24 Prednisone 22 Vincristine 21 Phantoms, Imaging 21 cabozantinib 20 durvalumab 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × adacel × 30 days × Clear all

NCT05237947 2026-05-28

PRISMA

National Cancer Institute (NCI)

Phase 4 Active not recruiting

Human Papillomavirus-Related Cervical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡